Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 98,243Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Melinta Therapeutics

02 1The Medicines Company UK Ltd,

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

Brand Name : ORBACTIV

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 400MG BASE/VIAL

Packaging :

Approval Date : 2014-08-06

Application Number : 206334

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ORITAVANCIN DIPHOSPHATE

Brand Name : KIMYRSA

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 1.2GM BASE/VIAL

Packaging :

Approval Date : 2021-03-12

Application Number : 214155

Regulatory Info : RX

Registration Country : USA

blank

03

The Medicines Company UK Ltd,

Country
2024 ACI Convention
Not Confirmed
arrow

The Medicines Company UK Ltd,

Country
arrow
2024 ACI Convention
Not Confirmed

oritavancindifosfat

Brand Name : Orbactiv

Dosage Form : PULVER TILL KONCENTRAT TILL

Dosage Strength : 400 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank